KR101749330B1 - 목이버섯이 배양된 황칠나무의 추출물을 유효성분으로 함유하는 화장품 조성물 - Google Patents
목이버섯이 배양된 황칠나무의 추출물을 유효성분으로 함유하는 화장품 조성물 Download PDFInfo
- Publication number
- KR101749330B1 KR101749330B1 KR1020150188384A KR20150188384A KR101749330B1 KR 101749330 B1 KR101749330 B1 KR 101749330B1 KR 1020150188384 A KR1020150188384 A KR 1020150188384A KR 20150188384 A KR20150188384 A KR 20150188384A KR 101749330 B1 KR101749330 B1 KR 101749330B1
- Authority
- KR
- South Korea
- Prior art keywords
- skin
- extract
- mushroom
- mixture
- rice bran
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000284 extract Substances 0.000 title claims abstract description 79
- 239000000203 mixture Substances 0.000 title claims abstract description 52
- 239000002537 cosmetic Substances 0.000 title claims abstract description 25
- 239000004480 active ingredient Substances 0.000 title claims abstract description 9
- 241000202573 Dendropanax Species 0.000 title 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims abstract description 46
- 230000006872 improvement Effects 0.000 claims abstract description 19
- 230000037394 skin elasticity Effects 0.000 claims abstract description 15
- 230000002087 whitening effect Effects 0.000 claims abstract description 8
- 241000209094 Oryza Species 0.000 claims description 28
- 235000007164 Oryza sativa Nutrition 0.000 claims description 28
- 235000009566 rice Nutrition 0.000 claims description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 13
- 235000008397 ginger Nutrition 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 10
- 230000036560 skin regeneration Effects 0.000 claims description 6
- 239000002023 wood Substances 0.000 claims description 6
- 229940102465 ginger root Drugs 0.000 claims description 5
- 239000001841 zingiber officinale Substances 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 230000037330 wrinkle prevention Effects 0.000 claims description 4
- 244000131316 Panax pseudoginseng Species 0.000 claims description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 3
- 238000012258 culturing Methods 0.000 claims description 3
- 235000008434 ginseng Nutrition 0.000 claims description 3
- 241000233866 Fungi Species 0.000 claims 2
- 244000126002 Ziziphus vulgaris Species 0.000 claims 2
- 244000273928 Zingiber officinale Species 0.000 claims 1
- 239000010903 husk Substances 0.000 claims 1
- 230000003020 moisturizing effect Effects 0.000 abstract description 10
- 230000037303 wrinkles Effects 0.000 abstract description 5
- 230000001172 regenerating effect Effects 0.000 abstract 1
- 238000011218 seed culture Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 30
- 210000003491 skin Anatomy 0.000 description 29
- 230000000052 comparative effect Effects 0.000 description 20
- 241001247821 Ziziphus Species 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 15
- 239000008188 pellet Substances 0.000 description 15
- 238000009472 formulation Methods 0.000 description 13
- 241000234314 Zingiber Species 0.000 description 12
- 239000002674 ointment Substances 0.000 description 11
- 238000002835 absorbance Methods 0.000 description 9
- 102000016387 Pancreatic elastase Human genes 0.000 description 8
- 108010067372 Pancreatic elastase Proteins 0.000 description 8
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 8
- 102400000740 Melanocyte-stimulating hormone alpha Human genes 0.000 description 7
- 101710200814 Melanotropin alpha Proteins 0.000 description 7
- 230000032683 aging Effects 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 102000008186 Collagen Human genes 0.000 description 6
- 108010035532 Collagen Proteins 0.000 description 6
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 6
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 6
- 229920001436 collagen Polymers 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000003425 Tyrosinase Human genes 0.000 description 5
- 108060008724 Tyrosinase Proteins 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 230000008099 melanin synthesis Effects 0.000 description 5
- WHNFPRLDDSXQCL-UAZQEYIDSA-N α-msh Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)NC(=O)[C@H](CO)NC(C)=O)C1=CC=C(O)C=C1 WHNFPRLDDSXQCL-UAZQEYIDSA-N 0.000 description 5
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 229960000271 arbutin Drugs 0.000 description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 241000132536 Cirsium Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000012091 fetal bovine serum Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 210000001541 thymus gland Anatomy 0.000 description 3
- 238000003809 water extraction Methods 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 2
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 206010051246 Photodermatosis Diseases 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 230000036564 melanin content Effects 0.000 description 2
- 210000002686 mushroom body Anatomy 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 230000008845 photoaging Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000036559 skin health Effects 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- TYMLOMAKGOJONV-UHFFFAOYSA-N 4-nitroaniline Chemical compound NC1=CC=C([N+]([O-])=O)C=C1 TYMLOMAKGOJONV-UHFFFAOYSA-N 0.000 description 1
- 240000000662 Anethum graveolens Species 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 240000008384 Capsicum annuum var. annuum Species 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 230000009946 DNA mutation Effects 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 235000009414 Elaeocarpus kirtonii Nutrition 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 241000123107 Phellinus Species 0.000 description 1
- 241001600434 Plectroglyphidodon lacrymatus Species 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 241001646071 Prioneris Species 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 244000236151 Tabebuia pallida Species 0.000 description 1
- 235000013584 Tabebuia pallida Nutrition 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000006851 antioxidant defense Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002849 elastaseinhibitory effect Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229940069328 povidone Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A61K8/975—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
Description
시료 | Cell viability (%) |
- | 100 |
실시예 1 추출물 | 99.9 ± 0.07 |
실시예 2 추출물 | 99.4 ± 0.08 |
실시예 3 추출물 | 99.5 ± 0.05 |
실시예 4 추출물 | 99.1 ± 0.03 |
실시예 5 추출물 | 99.0 ± 0.02 |
비교예 1 추출물 | 99.9 ± 0.05 |
시료 | Tyrosinase activity (%) |
α-MSH(-) | - |
α-MSH(+, 100 nM) | 100 |
α-MSH(+) + Arbutin (100 μM) | 82.3 ± 0.04 |
α-MSH(+) + 실시예 1 추출물 | 77.7 ± 0.07 |
α-MSH(+) + 실시예 2 추출물 | 72.4 ± 0.04 |
α-MSH(+) + 실시예 3 추출물 | 65.5 ± 0.02 |
α-MSH(+) + 실시예 4 추출물 | 62.1 ± 0.01 |
α-MSH(+) + 실시예 5 추출물 | 49.4 ± 0.06 |
α-MSH(+) + 비교예 1 추출물 | 82.5 ± 0.05 |
시료 | Melanin contents (%) |
α-MSH(-) | - |
α-MSH(+, 100 nM) | 100 |
α-MSH(+) + Arbutin (100 μM) | 59.1 ± 0.04 |
α-MSH(+) + 실시예 1 추출물 | 52.4 ± 0.07 |
α-MSH(+) + 실시예 2 추출물 | 45.2 ± 0.04 |
α-MSH(+) + 실시예 3 추출물 | 43.5 ± 0.02 |
α-MSH(+) + 실시예 4 추출물 | 44.1 ± 0.01 |
α-MSH(+) + 실시예 5 추출물 | 35.4 ± 0.06 |
α-MSH(+) + 비교예 1 추출물 | 60.3 ± 0.05 |
추출물 | 엘라스타제 저해율(%) |
실시예 1 추출물 | 43.9 |
실시예 2 추출물 | 55.8 |
실시예 3 추출물 | 59.8 |
실시예 4 추출물 | 64.8 |
실시예 5 추출물 | 67.7 |
비교예 1 추출물 | 31.2 |
배합성분 | 함량(중량%) | |||||
제형 1 | 제형 2 | 제형 3 | 제형 4 | 제형 5 | 비교 제형 |
|
실시예 1 추출물 | 1.00 | - | - | - | - | - |
실시예 2 추출물 | - | 1.00 | - | - | - | - |
실시예 3 추출물 | - | - | 1.00 | - | - | - |
실시예 4 추출물 | - | - | - | 1.00 | - | - |
실시예 5 추출물 | - | - | - | - | 1.00 | - |
비교예 1 추출물 | - | - | - | - | - | 1.00 |
스쿠알란 | 5.0 | 5.0 | 5.0 | 5.0 | ||
밀납 | 4.0 | 4.0 | 4.0 | 4.0 | ||
폴리솔베이트 60 | 1.5 | 1.5 | 1.5 | 1.5 | ||
솔비탄세스퀴올레이트 | 1.5 | 1.5 | 1.5 | 1.5 | ||
유동파라핀 | 0.5 | 0.5 | 0.5 | 0.5 | ||
카프릴릭/카프릭트리글리세라이드 | 5.0 | 5.0 | 5.0 | 5.0 | ||
글리세린 | 3.0 | 3.0 | 3.0 | 3.0 | ||
프로필렌글리콜 | 3.0 | 3.0 | 3.0 | 3.0 | ||
카르복시비닐폴리머 | 0.1 | 0.1 | 0.1 | 0.1 | ||
트리에탄올아민 | 0.2 | 0.2 | 0.2 | 0.2 | ||
방부제, 향, 색소 | 적량 | 적량 | 적량 | 적량 | ||
정제수 | 잔량 | 잔량 | 잔량 | 잔량 |
제형예 | 피부보습효과(%) | 피부탄력 개선도효과(%) |
제형 1 | 34 | 42 |
제형 2 | 39 | 48 |
제형 3 | 48 | 54 |
제형 4 | 55 | 58 |
제형 5 | 61 | 63 |
비교 제형 | 12 | 18 |
Claims (6)
- 채취한 뿌리, 잎, 줄기 및 가지로 이루어진 군에서 선택되는 어느 하나 이상의 황칠나무를 거핵 대추 및 생강 달인 물에 침지 시킨 다음 목이버섯 균을 배양한 후 상기 목이버섯이 배양된 황칠나무를 추출한 추출물을 유효성분으로 함유하는 화장품 조성물.
- 제 1항에 있어서,
상기 거핵 대추 및 생강 달인 물에 침지 시킨 황칠나무에 쌀겨를 혼합한 후 이 혼합물에 목이버섯 균을 배양하는 것을 특징으로 하는 화장품 조성물.
- 제 1항 또는 2항에 있어서,
상기 추출물은 열수 추출물이며, 피부 미백, 피부 주름 방지, 피부 탄력 개선, 피부 재생 및 피부 보습에 유효한 것을 특징으로 하는 화장품 조성물.
- 채취한 뿌리, 잎, 줄기 및 가지로 이루어진 군에서 선택되는 어느 하나 이상의 황칠나무에 쌀겨를 혼합한 후 이 혼합물에 목이버섯 균을 배양후 상기 목이버섯이 배양된 상기 황칠나무 및 쌀겨 혼합물을 추출한 추출물을 유효성분으로 함유하는 화장품 조성물.
- 제 4항에 있어서,
상기 황칠나무에 쌀겨를 혼합한 혼합물을 거핵 대추 및 생강 달인 물에 침지 시킨 후 목이버섯 균을 배양하는 것을 특징으로 하는 화장품 조성물.
- 제 4항 또는 5항에 있어서, 상기 추출물은 열수 추출물이며, 피부 미백, 피부 주름 방지, 피부 탄력 개선, 피부 재생 및 피부 보습에 유효한 것을 특징으로 하는 화장품 조성물.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150188384A KR101749330B1 (ko) | 2015-12-29 | 2015-12-29 | 목이버섯이 배양된 황칠나무의 추출물을 유효성분으로 함유하는 화장품 조성물 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150188384A KR101749330B1 (ko) | 2015-12-29 | 2015-12-29 | 목이버섯이 배양된 황칠나무의 추출물을 유효성분으로 함유하는 화장품 조성물 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101749330B1 true KR101749330B1 (ko) | 2017-06-20 |
Family
ID=59281047
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020150188384A Active KR101749330B1 (ko) | 2015-12-29 | 2015-12-29 | 목이버섯이 배양된 황칠나무의 추출물을 유효성분으로 함유하는 화장품 조성물 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101749330B1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101880031B1 (ko) * | 2016-08-25 | 2018-07-20 | 충남태안영농조합법인 | 황칠과 굼벵이를 이용한 중금속의 생체 내 흡수 방지 및 생체 외 배출을 위한 기능성 식품 조성물 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101176529B1 (ko) | 2009-12-31 | 2012-08-24 | 주식회사 코리아나화장품 | 황칠나무 추출물을 유효성분으로 함유하는 화장료 조성물 |
KR101353054B1 (ko) | 2012-01-17 | 2014-01-17 | 신형순 | 고로쇠 나무와 황칠 나무를 이용한 발효물 및 이의 제조방법 그리고 이를 이용한 식품 조성물 및 화장료 조성물 |
KR101387308B1 (ko) | 2012-12-03 | 2014-04-18 | 음준영 | 황칠나무 발효산물을 이용한 피부 미백 화장료 조성물 |
-
2015
- 2015-12-29 KR KR1020150188384A patent/KR101749330B1/ko active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101176529B1 (ko) | 2009-12-31 | 2012-08-24 | 주식회사 코리아나화장품 | 황칠나무 추출물을 유효성분으로 함유하는 화장료 조성물 |
KR101353054B1 (ko) | 2012-01-17 | 2014-01-17 | 신형순 | 고로쇠 나무와 황칠 나무를 이용한 발효물 및 이의 제조방법 그리고 이를 이용한 식품 조성물 및 화장료 조성물 |
KR101387308B1 (ko) | 2012-12-03 | 2014-04-18 | 음준영 | 황칠나무 발효산물을 이용한 피부 미백 화장료 조성물 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101880031B1 (ko) * | 2016-08-25 | 2018-07-20 | 충남태안영농조합법인 | 황칠과 굼벵이를 이용한 중금속의 생체 내 흡수 방지 및 생체 외 배출을 위한 기능성 식품 조성물 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101828584B1 (ko) | 참여로, 가래나무, 도깨비 부채 및 모과나무의 복합추출물을 포함하는 항산화 또는 미백용 조성물 | |
JP7708495B2 (ja) | 抗老化剤、抗酸化剤、抗炎症剤、及び美白剤、並びに、化粧料 | |
KR101824770B1 (ko) | 적하수오 부정근 추출물을 함유하는 피부 주름개선 기능성 화장료 조성물 | |
JP6437297B2 (ja) | 特定の波長域を有する光を照射して栽培したセージの抽出物を含有する皮膚外用剤や内用剤 | |
KR102071218B1 (ko) | 사향, 당귀, 산수유, 녹용 및 상황버섯, 영지버섯, 차가버섯, 잎새버섯, 꽃송이버섯 추출물을 유효성분으로 함유하는 피부 주름개선용 화장료 조성물 | |
KR101390465B1 (ko) | 탁시폴린 배당체를 함유하는 작약추출물의 제조방법 및 작약추출물을 함유하는 화장료 조성물 | |
KR102526287B1 (ko) | 쌍별귀뚜라미 추출물의 발효물을 유효성분으로 함유하는 항염증 및 주름 개선용 조성물 | |
KR101810410B1 (ko) | 버섯 균사체 및 청호밀 태좌의 혼합 배양 추출물의 제조방법 및 이를 함유하는 화장료 조성물 | |
KR102017132B1 (ko) | 실론시나몬나무껍질 및 구릿대의 혼합발효추출물을 함유하는 화장료 조성물 | |
JP6595192B2 (ja) | 特定の波長域を有する光を照射して栽培したフェヌグリークの抽出物を含有する皮膚外用剤や内用剤。 | |
KR101749330B1 (ko) | 목이버섯이 배양된 황칠나무의 추출물을 유효성분으로 함유하는 화장품 조성물 | |
KR101957435B1 (ko) | 피부 주름 예방 또는 개선용 누에고치 발효물의 제조방법 및 이를 유효성분으로 함유하는 화장료 조성물 | |
KR101207559B1 (ko) | 윤노리나무 추출물을 유효성분으로 함유하는 화장료 조성물 | |
KR101960571B1 (ko) | 살구 추출물의 제조방법, 이로부터 제조된 살구 추출물 및 이를 유효 성분으로 포함하는 기능성 피부미용 또는 화장료 조성물 | |
KR101662805B1 (ko) | 비타민 강화 미강 추출물과 이를 이용한 미백 및 주름개선용 화장료 조성물 및 이의 제조방법 | |
KR101944494B1 (ko) | 털마삭줄을 포함하는 마삭줄속 식물 추출물을 유효성분으로 함유하는 화장료 조성물 | |
KR102114647B1 (ko) | 흑호두나무, 회화나무 및 소나무 추출 혼합물을 유효성분으로 함유하는 항노화 또는 항염용 화장료 조성물 | |
KR101207560B1 (ko) | 빗죽이나무 추출물을 유효성분으로 함유하는 화장료 조성물 | |
KR102002891B1 (ko) | 삼색도장버섯 추출물 및 삼색도장버섯 균사체로 발효시킨 발효물을 유효성분으로 포함하는 화장료 조성물 | |
JP2015221791A (ja) | 特定の波長域を有する光を照射して栽培したクウシンサイの抽出物を含有する皮膚外用剤や内用剤。 | |
KR101778538B1 (ko) | 인삼 열매 귀부균 발효물을 함유하는 화장료 조성물 | |
KR100529542B1 (ko) | 화장료 유효성분물질의 분리추출방법, 화장료 조성물 및 이를 이용한 화장료 | |
JP6595195B2 (ja) | 特定の波長域を有する光を照射して栽培したチコリの抽出物を含有する皮膚外用剤や内用剤 | |
KR102541810B1 (ko) | 안젤리카 및 크랜베리 추출물을 포함하는 피부 개선용 조성물 | |
KR20140115229A (ko) | 생약재의 추출물을 유효성분으로 포함하는 항산화 또는 미백용 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20151229 |
|
PA0201 | Request for examination | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20170419 Patent event code: PE09021S01D |
|
E90F | Notification of reason for final refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Final Notice of Reason for Refusal Patent event date: 20170510 Patent event code: PE09021S02D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20170529 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20170614 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20170615 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20200615 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20210614 Start annual number: 5 End annual number: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20240905 Start annual number: 8 End annual number: 8 |